Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding

European Journal of Medical Research

Volumn 18, Issue 1, 2013, Pages

  Hoaglin, David C ^b   Filonenko, Anna ^c   Glickman, Mark E ^d   Wasiak, Radek ^a   Gidwani, Risha ^e  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b Consulting Statistician ^*  (United States)

^c BAYER PHARMA AG   (Germany)

^d BOSTON UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; GESTAGEN; HEMATIN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ACCURACY; ARTICLE; BAYESIAN LEARNING; BLEEDING; COMPARATIVE STUDY; DRUG EFFICACY; ENDOMETRIUM ABLATION; FOLLOW UP; HUMAN; MENSTRUAL CYCLE; METHODOLOGY; METRORRHAGIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; STATISTICS; SYSTEMATIC REVIEW; BAYES THEOREM; FEMALE; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUATION; META ANALYSIS; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

BAYES THEOREM; DANAZOL; ENDOMETRIAL ABLATION TECHNIQUES; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENORRHAGIA; MENSTRUATION; PROGESTINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84879074092     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-18-17     Document Type: Article

References (35)

1. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Hallberg L, Hogdahl AM, Nilsson L, Rybo G, Acta Obstet Gynecol Scand 1966 45 3 320 351 10.3109/00016346609158455 5922481
2. National Collaborating Centre for Women's and Children's Health, Heavy menstrual bleeding. National Institute for Health and Clinical Excellence Clinical Guideline 2007 http://www.nice.org.uk/nicemedia/live/11002/30401/30401. pdf
3. An epidemiological survey of symptoms of menstrual loss in the community. Shapley M, Jordan K, Croft PR, Br J Gen Pract 2004 54 502 359 363 15113519 (Pubitemid 38584861)
4. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. Santer M, Warner P, Wyke S, J Clin Epidemiol 2005 58 11 1206 1210 10.1016/j.jclinepi.2005.02.026 16223665 (Pubitemid 41441710)
5. Work loss associated with increased menstrual loss in the United States. Cote I, Jacobs P, Cumming D, Obstet Gynecol 2002 100 4 683 687 10.1016/S0029-7844(02)02094-X 12383534 (Pubitemid 35300023)
6. Abnormal bleeding patterns associated with menorrhagia in women in the community and in women presenting to primary care. Shapley M, Jordan K, Croft PR, Fam Pract 2007 24 6 532 537 10.1093/fampra/cmm068 18032402
7. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD, Am J Obstet Gynecol 2004 190 5 1216 1223 10.1016/j.ajog.2003.11.015 15167821 (Pubitemid 38692200)
8. Assessment of the prevalence and impact of anemia on women hospitalized for gynecologic conditions associated with heavy uterine bleeding. Morrison J, Patel ST, Watson W, Zaidi QR, Mangione A, Goss TF, J Reprod Med 2008 53 5 323 330 18567277 (Pubitemid 351846376)
9. Oral contraceptive pill for heavy menstrual bleeding. Farquhar C, Brown J, Cochrane Database Syst Rev 2009 4 CD000154
10. Cyclical progestogens for heavy menstrual bleeding. Lethaby A, Irvine GA, Cameron IT, Cochrane Database Syst Rev 2008 1 CD001016
11. Antifibrinolytics for heavy menstrual bleeding. Lethaby A, Farquhar C, Cooke I, Cochrane Database Syst Rev 2000 4 CD000249
12. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Lethaby AE, Cooke I, Rees M, Cochrane Database Syst Rev 2005 4 CD002126
13. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States. Ganz ML, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J, Law A, Value Health 2013 16 2 325 333 10.1016/j.jval.2012.11.011 23538185
14. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Ades AE, Sculpher M, Sutton A, Abrams K, Cooper N, Welton N, Lu G, Pharmacoeconomics 2006 24 1 1 19 10.2165/00019053-200624010-00001 17266384 (Pubitemid 43197227)
15. Grade Working Group, http://www.gradeworkinggroup.org/
16. Determination of menstural blood loss. Hallberg L, Nilsson L, Scand J Clin Lab Invest 1964 16 244 248 10.3109/00365516409060511 14161862
17. Validation of a rapid alkaline hematin technique to measure menstrual blood loss on feminine towels containing superabsorbent polymers. Magnay JL, Schönicke G, Nevatte TM, O'Brien S, Junge W, Fertil Steril 2011 96 394 398 10.1016/j.fertnstert.2011.05.096 21719001
18. Assessment of menstrual blood loss using a pictorial chart. Higham JM, O'Brien PM, Shaw RW, Br J Obstet Gynaecol 1990 97 8 734 739 10.1111/j.1471-0528. 1990.tb16249.x 2400752 (Pubitemid 20263124)
19. Abnormal uterine bleeding: a review of patient-based outcome measures. Matteson KA, Boardman LA, Munro MG, Clark MA, Fertil Steril 2009 Jul 92 1 205 216 10.1016/j.fertnstert.2008.04.023
20. Gelman A, Hill J, Data analysis using regression and multilevel/ hierarchical models Cambridge, U.K.: Cambridge University Press 2007
21. Little RJA, Rubin DB, Statistical analysis with missing data Hoboken, NJ: John Wiley & Sons 2 2002
22. Making BUGS open. Thomas A, O'Hara B, Ligges U, Sturtz S, R News 2006 6 12 17 http://www.openbugs.info/w
23. General methods for monitoring convergence of iterative simulations. Brooks SP, Gelman A, J Comput Graph Stat 1998 7 434 455 (Pubitemid 128635035)
24. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M, J Obstet Gynaecol Can 2009 31 4 340 347 19497153
25. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized double-blind Phase III trial. Fraser IS, Römer T, Parke S, Zeun S, Mellinger U, Machlitt A, Jensen JT, Hum Reprod 2011 26 10 2698 2708 10.1093/humrep/der224 21784734
26. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: A randomized controlled trial. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS, Obstet Gynecol 2011 117 777 787 10.1097/AOG. 0b013e3182118ac3 21422847
27. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT, Obstet Gynecol 2010 116 3 625 632 10.1097/AOG.0b013e3181ec622b 20733445
28. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review. Kaunitz AM, Inki P, Drugs 2012 72 2 193 215 10.2165/11598960-000000000-00000 22268392
29. The binomial distribution of meta-analysis was preferred to model within-study variability. Hamza TH, Van Houwelingen HC, Stijnen T, J Clin Epidemiol 2008 61 41 51 10.1016/j.jclinepi.2007.03.016 18083461 (Pubitemid 350236698)
30. Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis. Daniels JP, Middleton LJ, Champaneria R, Khan KS, Cooper K, Mol BW, Bhattacharya S, International Heavy Menstrual Bleeding IPD Meta-analysis Collaborative Group, BMJ 2012 344 2564 10.1136/bmj.e2564 22529302
31. Surgery versus medical therapy for heavy menstrual bleeding. Marjoribanks J, Lethaby A, Farquhar C, Cochrane Database Syst Rev 2010 2 D003855 Updated (no change to conclusions), 2010
32. Levonorgestrel-releasing intrauterine system and endometrial ablation for heavy menstrual bleeding: A systematic review and meta-analysis. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L, Obstet Gynecol 2009 113 1104 1116 19384127
33. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. Middleton LJ, Champaneria R, Daniels JP, Bhattacharya S, Cooper KG, Hilken NH, O'Donovan P, Gannon M, Gray R, Khan KS, BMJ 2010 341 3929 10.1136/bmj.c3929 20713583
34. Danazol for heavy menstrual bleeding. Beaumont HH, Augood C, Duckitt K, Lethaby A, Cochrane Database Syst Rev 2007 3 CD001017
35. How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? Cooper NJ, Peters J, Lai MCW, Juni P, Wandel S, Palmer S, Paulden M, Conti S, Welton NJ, Abrams KR, Bujkiewicz S, Spiegelhalter D, Sutton AJ, Value Health 2011 14 371 380 10.1016/j.jval.2010.09.001 21296599